OC-0259: Validation of a multi-atlas based auto-segmentation of the heart in breast cancer patients

Femke B. J. van Dijk-Peters; Nanna Maria Sijtsema; Roel G J Kierkels; Rozemarijn Vliegenthart; J.A. Langendijk; John Maduro; Anne Crijns

doi:10.1016/S0167-8140(15)40257-9

OC-0259: Validation of a multi-atlas based auto-segmentation of the heart in breast cancer patients

Femke B. J. van Dijk-Peters
, Nanna Maria Sijtsema
, Roel G J Kierkels
, Rozemarijn Vliegenthart
, J.A. Langendijk
, John Maduro
, Anne Crijns

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S132-S133
Number of pages	2
Journal	Radiotherapy and Oncology
Volume	115
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/S0167-8140(15)40257-9
Publication status	Published - Apr-2015

Access to Document

10.1016/S0167-8140(15)40257-9Licence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

@article{f70892fc891d46dea17a836d926d8e22,

title = "OC-0259: Validation of a multi-atlas based auto-segmentation of the heart in breast cancer patients",

author = "\{van Dijk-Peters\}, \{Femke B. J.\} and Sijtsema, \{Nanna Maria\} and Kierkels, \{Roel G J\} and Rozemarijn Vliegenthart and J.A. Langendijk and John Maduro and Anne Crijns",

year = "2015",

month = apr,

doi = "10.1016/S0167-8140(15)40257-9",

language = "English",

volume = "115",

pages = "S132--S133",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "ELSEVIER IRELAND LTD",

number = "Supplement 1",

}

TY - JOUR

T1 - OC-0259: Validation of a multi-atlas based auto-segmentation of the heart in breast cancer patients

AU - van Dijk-Peters, Femke B. J.

AU - Sijtsema, Nanna Maria

AU - Kierkels, Roel G J

AU - Vliegenthart, Rozemarijn

AU - Langendijk, J.A.

AU - Maduro, John

AU - Crijns, Anne

PY - 2015/4

Y1 - 2015/4

U2 - 10.1016/S0167-8140(15)40257-9

DO - 10.1016/S0167-8140(15)40257-9

M3 - Meeting Abstract

SN - 0167-8140

VL - 115

SP - S132-S133

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - Supplement 1

ER -